Kate Fynes
Head of CMC, eXmoor Pharma
False
Advertisement
Building a CAR-T CMC Strategy on a Limited Budget
October 6, 2026
Early developers do not need a finalized commercial process before first-in-human studies, but they do need a clear plan for managing cost, scalability, comparability, and future manufacturing changes
7 min read
Newsletters
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.
